TP
CH
BRDL
TB
JLKR
GGPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Axsome Therapeuticsaxsome.com  CR GJ NR |
Axsome Therapeutics is a biopharmaceutical company developing novel CNS therapies, including AXS-05, AXS-12, and AXS-14, for condi | New York, New York | 1001-5000 | — |
Acadia Pharmaceuticalsacadia.com  LCFL SC |
Acadia Pharmaceuticals is a publicly traded biopharmaceutical company developing and commercializing treatments for underserved ne | San Diego, California | 1001-5000 | — |
Neurocrine Biosciencesneurocrine.com AH  CH SB |
Neurocrine Biosciences is a biopharmaceutical company founded in 1992 that discovers, develops, and commercializes FDA-approved tr | San Diego, California | 1001-5000 | — |
Biogenbiogen.com  JBMÇJB |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Neumoraneumoratx.com DW  LE SB |
Neumora Therapeutics is a precision neuroscience company developing novel therapies for brain diseases, including neuropsychiatric | Watertown, Massachusetts | 51-200 | — |
Intra-Cellular Therapiesintracellulartherapies.com |
Intra-Cellular Therapies is a biopharmaceutical company developing drugs for the treatment of neuropsychiatric and neurologic dise | New York, New York | 201-1000 | — |
SAGE Therapeuticssagerx.com |
SAGE Therapeutics develops and delivers novel medicines for the most debilitating and disabling central nervous system disorders, | Brighton, Massachusetts | 201-1000 | — |
Jazzpharmajazzpharma.com TSCY  BP |
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a biopharmaceutical company developing and commercializing innovative medicines for pat | — | — | — |
Supernus Pharmaceuticalssupernus.com KDBWJB |
Supernus Pharmaceuticals is a biopharmaceutical company developing and commercializing products for central nervous system (CNS) d | Rockville, Maryland | 201-1000 | — |
Alkermesalkermes.com  MO DWGC |
Alkermes is a global biopharmaceutical company developing and commercializing medicines for complex psychiatric and neurological d | — | — | — |
Lundbecklundbeck.com SK  AMJS |
Lundbeck is a Danish pharmaceutical company with more than 70 years of neuroscience expertise, one of the few companies focusing e | — | — | — |
Incyteincyte.com JF  SV RL |
Incyte is a global biopharmaceutical company that discovers, develops, and commercializes innovative medicines for patients with u | Wilmington, Delaware | 1001-5000 | — |
AbbVieabbvie.com KMJM  KS |
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health iss | North Chicago, Illinois | 5000+ | — |
Pfizerpfizer.com  JDKPSH |
Pfizer is one of the world's premier biopharmaceutical companies, developing and manufacturing medicines and vaccines across inter | New York, New York | 5000+ | — |
Eliem Therapeuticseliemtx.com |
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders, operating from Re | Redmond, Washington | 11-50 | — |
Bioviepharmabioviepharma.com |
BioVie is a biotechnology company developing small molecule therapeutics, including its flagship bezisterim (NE3107), to target ch | Carson City, Nevada | 11-50 | — |
EmbarkNeuroembarkneuro.com |
EmbarkNeuro is a biotechnology company founded in 2019 that develops personalized therapies for individuals with mental health con | oakland, California | 1-10 | — |
Aytu BioPharmaaytubio.com |
Aytu BioPharma (NASDAQ: AYTU) is a specialty biopharmaceutical company focused on advancing innovative medicines for complex centr | Denver, Colorado | 51-200 | — |
SHINKEI Therapeuticsshinkeitherapeutics.com |
SHINKEI is a clinical-stage pharmaceutical company based in Princeton, New Jersey, using the 505(b)2 regulatory strategy to repurp | Princeton, New Jersey | 1-10 | — |
Targeted Pharmaceuticalstargetedpharma.com |
Targeted Pharmaceuticals is a cannabinoid-based drug discovery and personalized medicine company based in Worcester, Massachusetts | Worcester, Massachusetts | 1-10 | — |
Minerva Neurosciencesminervaneurosciences.com |
Minerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company developing a portfolio of product candidates to | Waltham, Massachusetts | 1-10 | — |
Jaya Biosciencesjayabio.com |
Jaya Biosciences is an early-stage life sciences company developing CNS-directed gene therapies for genetically defined neurodegen | South San Francisco, California | 1-10 | — |
Aperture Therapeuticsaperturetx.com |
Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodege | San Carlos, California | 1-10 | — |
Leucadia Therapeuticsleucadiatx.com |
Leucadia Therapeutics is a preclinical-stage biotechnology company developing Arethusta®, a first-in-class outpatient treatment fo | RIverside, California | 1-10 | — |
Spine BioPharmaspinebiopharma.com |
Spine BioPharma is a biotechnology company developing non-surgical, non-opiate therapies for degenerative spine-related diseases, | New York, New York | 1-10 | — |
Curemarkcuremark.com |
Curemark is a clinical-stage biopharmaceutical company developing therapies for neurological and developmental disorders, with a p | Rye, New York | 11-50 | — |
BioXcel Therapeuticsbioxceltherapeutics.com |
BioXcel Therapeutics is a biopharmaceutical company developing medicines in neuroscience, including an at-home Phase 3 trial for a | New Haven, Connecticut | 51-200 | — |
Aviv Clinicsaviv-clinics.com |
Aviv Clinics is a network of medical centers applying data science and AI to treat age-related cognitive and functional decline, o | The Villages, Florida | 11-50 | — |
Lucy Therapeuticslucytherapeutics.com |
Lucy Therapeutics is a private biotech company developing proprietary small molecule therapies and diagnostic biomarkers for compl | Waltham, Massachusetts | 1-10 | — |
Harmony Biosciencesharmonybiosciences.com |
Harmony Biosciences is a biopharmaceutical company developing and delivering innovative therapies for patients with rare neurologi | Plymouth Meeting, Pennsylvania | 201-1000 | — |
| Run live for more | ||||
Axsome Therapeutics is a biopharmaceutical company developing novel CNS therapies, including AXS-05, AXS-12, and AXS-14, for conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia.
Companies like Axsome Therapeutics include Acadia Pharmaceuticals, Neurocrine Biosciences, Biogen, Neumora, Intra-Cellular Therapies. See the full list of 24 competitors and alternatives above.
Axsome Therapeutics has approximately 1001-5000 employees and is in the Biotechnology Research industry.
Axsome Therapeutics is headquartered in New York, New York.
Axsome Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Axsome Therapeutics are listed above, including leaders across executive, finance, sales and operations.